Recent transactions
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Smith Nicholas Conrad | Pres, CFO | S SaleOE | — | $26.45 | $3.6M | filing |
ALTO NEUROSCIENCE IN (ANRO) insider trading activity (SEC Form 4). Over the trailing 90 days, ANRO insiders filed 0 purchases totalling $0 and 1 sales totalling $3.6M — net SELLING of $3.6M. Most recent filing: Oct 1, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Smith Nicholas Conrad | Pres, CFO | S SaleOE | — | $26.45 | $3.6M | filing |